Documentos relacionados

1. Results of neonatal screening for congenital hypothyroidism and hyperphenylalaninemia in Zhejiang province from 1999 to 2022.
2. Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism.
3. Newborn screening for congenital hypothyroidism and phenylketonuria-Beyond cost savings.
4. Optimization and validation of a bioanalytical HPLC-UV technique for simultaneous determination of underivatized phenylalanine and tyrosine in the blood for phenylketonuria diagnosis and monitoring.
5. Identification of phenylketonuria patient genotypes using single-gene full-length sequencing.
6. A Comprehensive Study of Disease-Causing Variants in PAH, QDPR, PTS, and PCD Genes in Iranian Patients with Hyperphenylalaninemia: A Systematic Review.
7. Allelic phenotype prediction of phenylketonuria based on the machine learning method.
8. Identification of novel deep intronic PAH gene variants in patients diagnosed with phenylketonuria.
9. Past, present and future of newborn screening in Chile.
10. Newborn screening in southeastern Europe.